Literature DB >> 15480072

The regulation of chondrocyte function by proinflammatory mediators: prostaglandins and nitric oxide.

Mary B Goldring1, Francis Berenbaum.   

Abstract

Within the mature articular cartilage matrix, which has no blood or nerve supply, chondrocytes show little metabolic activity with low turnover of matrix components. Under conditions of stress because of biomechanical factors, however, chondrocytes are capable of producing mediators that are associated with inflammation, including cytokines such as interleukin-1 and tumor necrosis factor-alpha, which in turn stimulate the production of prostaglandins and nitric oxide. Chondrocytes also express receptors for these mediators, which accumulate at high local concentrations and can act in an autocrine-paracrine fashion to feedback-regulate chondrocyte responses. Prostaglandin E2 can exert catabolic or anabolic effects depending on the microenvironment. Nitric oxide can promote cellular injury and increase chondrocyte susceptibility to cytokine-induced apoptosis. Because cross-talk between these mediators produces complex modulation of catabolic and anabolic pathways, further studies in vitro and in vivo are required to elucidate their precise roles in osteoarthritis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15480072     DOI: 10.1097/01.blo.0000144484.69656.e4

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  72 in total

Review 1.  Regulation of chondrogenesis and chondrocyte differentiation by stress.

Authors:  Michael J Zuscik; Matthew J Hilton; Xinping Zhang; Di Chen; Regis J O'Keefe
Journal:  J Clin Invest       Date:  2008-02       Impact factor: 14.808

Review 2.  A current review of molecular mechanisms regarding osteoarthritis and pain.

Authors:  Andrew S Lee; Michael B Ellman; Dongyao Yan; Jeffrey S Kroin; Brian J Cole; Andre J van Wijnen; Hee-Jeong Im
Journal:  Gene       Date:  2013-07-02       Impact factor: 3.688

3.  The synovial fluid adiponectin-leptin ratio predicts pain with knee osteoarthritis.

Authors:  Rajiv Gandhi; Mark Takahashi; Holly Smith; Randy Rizek; Nizar N Mahomed
Journal:  Clin Rheumatol       Date:  2010-03-28       Impact factor: 2.980

4.  The chondroprotective effects of ferulic acid on hydrogen peroxide-stimulated chondrocytes: inhibition of hydrogen peroxide-induced pro-inflammatory cytokines and metalloproteinase gene expression at the mRNA level.

Authors:  M P Chen; S H Yang; C H Chou; K C Yang; C C Wu; Y H Cheng; Feng-Huei Lin
Journal:  Inflamm Res       Date:  2010-03-28       Impact factor: 4.575

Review 5.  Chondropenia: current concept review.

Authors:  A Speziali; M Delcogliano; M Tei; G Placella; M Chillemi; R Tiribuzi; G Cerulli
Journal:  Musculoskelet Surg       Date:  2015-06-13

6.  A role for interleukins in ochronosis in a chondrocyte in vitro model of alkaptonuria.

Authors:  J B Mistry; D J Jackson; M Bukhari; A M Taylor
Journal:  Clin Rheumatol       Date:  2015-10-16       Impact factor: 2.980

7.  A 3D cartilage - inflammatory cell culture system for the modeling of human osteoarthritis.

Authors:  Lin Sun; Xiuli Wang; David L Kaplan
Journal:  Biomaterials       Date:  2011-05-12       Impact factor: 12.479

8.  Hyaluronan fragments activate nitric oxide synthase and the production of nitric oxide by articular chondrocytes.

Authors:  Stanca Iacob; Cheryl B Knudson
Journal:  Int J Biochem Cell Biol       Date:  2005-09-08       Impact factor: 5.085

9.  Cytokine profile of autologous conditioned serum for treatment of osteoarthritis, in vitro effects on cartilage metabolism and intra-articular levels after injection.

Authors:  Marijn Rutgers; Daniël B F Saris; Wouter J A Dhert; Laura B Creemers
Journal:  Arthritis Res Ther       Date:  2010-06-10       Impact factor: 5.156

10.  Antirheumatic drug response signatures in human chondrocytes: potential molecular targets to stimulate cartilage regeneration.

Authors:  Kristin Andreas; Thomas Häupl; Carsten Lübke; Jochen Ringe; Lars Morawietz; Anja Wachtel; Michael Sittinger; Christian Kaps
Journal:  Arthritis Res Ther       Date:  2009-02-03       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.